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Abstract
African trypanosomiasis (AT), caused by Trypanosoma brucei species, results in both neu-
rological and cardiac dysfunction and can be fatal if untreated. Research on the pathogene-
sis and treatment of the disease has centred to date on the characteristic neurological
symptoms, whereas cardiac dysfunction (e.g. ventricular arrhythmias) in AT remains largely
unstudied. Animal models of AT demonstrating cardiac dysfunction similar to that described
in field cases of AT are critically required to transform our understanding of AT-induced car-
diac pathophysiology and identify future treatment strategies. We have previously shown
that T. brucei can interact with heart muscle cells (cardiomyocytes) to induce ventricular ar-
rhythmias in ex vivo adult rat hearts. However, it is unknown whether the arrhythmias ob-
served ex vivo are also present during in vivo infection in experimental animal models. Here
we show for the first time the characterisation of ventricular arrhythmias in vivo in two animal
models of AT infection using electrocardiographic (ECG) monitoring. The first model utilised
a commonly used monomorphic laboratory strain, Trypanosoma brucei brucei Lister 427,
whilst the second model used a pleomorphic laboratory strain, T. b. brucei TREU 927,
which demonstrates a similar chronic infection profile to clinical cases. The frequency of
ventricular arrhythmias and heart rate (HR) was significantly increased at the endpoint of in-
fection in the TREU 927 infection model, but not in the Lister 427 infection model. At the end
of infection, hearts from both models were isolated and Langendorff perfused ex vivo with
increasing concentrations of the β-adrenergic agonist isoproterenol (ISO). Interestingly, the
increased frequency of arrhythmias observed in vivo in the TREU 927 infection model was
lost upon isolation of the heart ex vivo, but re-emerged with the addition of ISO. Our results
demonstrate that TREU 927 infection modifies the substrate of the myocardium in such a
way as to increase the propensity for ventricular arrhythmias in response to a circulating fac-
tor in vivo or β-adrenergic stimulation ex vivo. The TREU 927 infection model provides a
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new opportunity to accelerate our understanding of AT-related cardiac pathophysiology and
importantly has the required sensitivity to monitor adverse cardiac-related electrical dys-
function when testing new therapeutic treatments for AT.
Author Summary
African trypanosomiasis (AT) is a disease caused by the single-celled protozoan parasite
Trypanosoma brucei. In humans, AT causes neurological problems including sleep dis-
turbances, which give the disease its colloquial name of “sleeping sickness”. Much of the
focus of AT research has been on the neurological deficits, but other major organs are
also affected, including the heart. Previous studies in humans and animals with AT have
identified heart abnormalities such as contractile dysfunction, ventricular arrhythmias
and significant cardiac tissue inflammation post-mortem. The need for studies investi-
gating AT-induced cardiac dysfunction is critically important. There is a growing cardio-
vascular disease (CVD) burden in the population of Sub-Saharan Africa and CVD is now
considered the leading cause of death in those aged over 45. AT-induced cardiac dysfunc-
tion has the potential to compound poor outcome in patients with pre-existing CVD and
those being treated with existing AT medications due to their inherent adverse cardiac ef-
fects. As a consequence, new treatments for AT require evaluation in appropriate pre-
clinical animal models to ensure that they do not detrimentally alter cardiac function.
This study established two rat models of AT infection in which an electrocardiogram
(ECG) was used to study cardiac electrical function. The first model utilised a commonly
used laboratory strain, Trypanosoma brucei brucei Lister 427, whilst the second model
used a laboratory strain that demonstrates a similar chronic infection profile to clinical
cases, T. b. brucei TREU 927. The TREU 927 infection model showed a significantly in-
creased frequency of cardiac arrhythmias in vivo. The arrhythmias observed in vivo in
the TREU 927 infection model were lost upon isolation of the heart ex vivo, but returned
with the addition of the β-adrenergic agonist—isoproterenol (ISO). These data suggest
that AT alters the myocardium in such a way as to increase the propensity for ventricular
arrhythmias when in the presence of a circulating factor or β-adrenergic stimulation
(stress). Importantly, this animal model has sufficient sensitivity to measure changes in
the frequency of AT-induced ventricular arrhythmias. Therefore the model is of value for
studies aiming to develop new treatment strategies to specifically minimise AT-related
cardiac dysfunction or to assess the presence of adverse cardiac electrical abnormalities
when testing new trypanocidal-based AT treatments.
Introduction
Human African trypanosomiasis (HAT) is caused by the Trypanosoma brucei sub-species T.
b. gambiense and T. b. rhodesiense, which are transmitted by the tsetse fly vector (Glossina
spp.). Infection with these parasites leads to both neurological and cardiac dysfunction and
can be fatal if untreated. The rate of disease progression and severity of clinical signs is depen-
dent upon a number of factors including parasite species and strain. Whilst the neurological-
related pathogenesis of African Trypanosomiasis (AT) infection has been an understandable
research focus leading to its extensive characterisation [1–3], the pathogenesis associated with
cardiac dysfunction is poorly understood. A better understanding of the cardiac-related
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pathogenesis of the disease is required because it is unknown: 1) how AT infection leads to
cardiac pathology; 2) whether infection level or stage alters the severity and progression of
cardiac dysfunction; 3) if the toxicity of drugs used to treat HAT could be exacerbated by AT-
induced cardiac pathology; and 4) if direct treatment of the cardiac pathology can improve
overall patient outcome.
HAT manifests clinically in two stages: Stage I, the haemolymphatic stage; and Stage II, the
meningo-encephalitic stage where the parasites extravasate into organs including the brain
[4–6] and heart [7;8]. Post-mortem studies clearly demonstrate that cardiac pathology occurs
in 70–100% of HAT patients [7;9] and in experimental animal models of the disease [10–14].
The observed cardiac pathologies include myocarditis [9] with mononuclear inflammatory
cell infiltration and fibrosis [7;8], both of which can lead to ventricular dysfunction and heart
failure. In a study of sixteen HAT deaths from T. b. gambiense, Adams et al. (1986) found that
two of the deaths were the result of pulmonary oedema from cardiac failure [7]. Furthermore,
radiographs from two separate studies demonstrated an enlargement of the cardiac silhouette
to>50% of the thoracic diameter (a potential indicator of cardiac failure) in 34% (of 118 [15])
and 44% (of 25 [16]) of patients with HAT (reviewed in Blum et al. 2008 [17]). Echocardiogra-
phy of HAT patients is not commonly assessed, but Tsala et al. (1988) in a study of 25 HAT
patients, identified potential indicators of heart failure including right-ventricular dilatation
in 64% of HAT patients and pericardial effusion in 12% [16]. Fouchet et al. (1968) [18] and
Bertrand et al. (1974) [15] have both reported cardiac conduction abnormalities, including
type I Atrio-Ventricular (AV) block in 3.7% and 14% of patients examined and type II AV
block in 1% and 2.5% of patients, respectively [15;18;19]. Conduction abnormalities can lead
to disturbances in heart rate and rhythm, leading to impaired delivery of blood to the tissues.
Palpitations resulting from ventricular arrhythmias called ventricular premature complexes
(VPCs) are indicators of heart dysfunction. HAT patients have significantly more palpitations
than controls [19]. A number of studies demonstrated a clear involvement of the cardiac pa-
thology in death [7;15;20;21], but because of the logistical difficulties of performing significant
field studies in the regions involved, understanding the true extent to which this occurs in
HAT is currently limited. A more recent large scale study that collected significant quantities
of cardiac data from T. b. gambienseHAT patients observed a high prevalence of cardiac elec-
trical abnormalities in ~55% of 406 stage I HAT patients and ~71% of 60 stage II HAT pa-
tients [19;22]. This study also demonstrated a significant proportion of patients with: (i)
prolonged QT interval which can lead to fatal arrhythmias; and (ii) increased levels of the pep-
tide NT- proBNP, an indicator of left ventricular dysfunction [19]. The extent of electrical ab-
normalities reported in patients with HAT in the study by Blum et el (71%) [19] is in striking
agreement with the proportion of patients with cardiac pathology observed at post-mortem
[7;9]. In addition to T. b. gambienseHAT patients, ECG abnormalities have also been identi-
fied in 55% (22 of 40) of patients with East African trypanosomiasis caused by T. b. rhode-
siense (unclassified for stage I or II disease) [23].
Besides the inevitable inflammatory response to trypanosomes that occurs in heart tissues,
we have previously demonstrated that T. brucei directly interact with heart muscle cells (cardi-
omyocytes) to induce ventricular arrhythmias (VPCs) in ex vivo hearts independent of a sys-
temic immune/inflammatory response [24]. However, it is unknown whether the arrhythmias
observed in rat hearts ex vivo are also present during infection in vivo.
The main aim of the current study was to develop an animal model of AT infection to assess
whether ventricular arrhythmias—in particular VPCs—could be identified in vivo through
electrocardiographic (ECG) assessment. The data suggest for the first time that AT infections
create an arrhythmogenic substrate in the heart, which when triggered by circulating factor/s
associated with β-adrenergic stimulation, increase the propensity for ventricular arrhythmias.
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Methods
Preparation of Trypanosomes
T. b. brucei Lister 427 and T. b. brucei TREU 927 were grown separately for one passage in ICR
mice for 2–3 days to adapt them to in vivo conditions, from being culture adapted in the case
of T. b. brucei Lister 427 [25] and from cryopreservation for T. b. brucei TREU 927. When
parasitaemia reached 1 x 108 parasites.mL-1 [26] the mice were euthanased and blood collected
in Carter’s balanced salt solution (CBSS; mM; 25 HEPES, 120 NaCl, 5.4 KCl, 0.55 CaCl2, 0.4
MgSO4, 5.6 Na2PO4, 11.1 glucose, pH 7.4) containing 100 U/ml heparin. The trypanosomes
were diluted to 1 x 105 parasites in a 200 μL volume of CBSS (approx. 1:200 dilution from 1
x108 parasites.mL-1) under sterile conditions. The 200 μL parasite suspension was prepared in
a 1 mL syringe for injection. Matching volumes of CBSS were prepared as control injections.
All mice and rat animal procedures were approved by the University of Glasgow Ethical Review
Panel and licensed by the Home Office, UK (Project Licence Number 600/4503).
Animals
The care and use of animals was in accordance with the UK government Animals (Scientific
procedures) Act 1986 (ASPA). Animals used were adult male Wistar rats (250–300g) with a 7
day acclimatisation period upon delivery with a 12 hr light/dark cycle. Animals were kept at
the Cardiovascular Research Unit, University of Glasgow in a dedicated room licensed under
the Specified Animal Pathogens (Scotland) Order, 2009 (SAPO).
ECG Acquisition for the Lister 427 Infection Model
Anaesthesia was induced by placing the animal in a pre-filled induction chamber with 5%
isoflurane (Isoflo, Abbot Laboratories, USA) in 100% O2 at 1 L.min
-1 until loss of righting
and flexor withdrawal reflexes. The rats were then maintained on isoflurane delivered via
facemask at 1–1.5% isoflurane in 1 L.min-1 O2. The lead II ECG was recorded via the place-
ment of sterile intradermal electrodes. The placement sites on the rat were caudal aspects of
the left and right carpi and the medial aspects of left and right crura. To ensure reproducibili-
ty for the same rats and between rats, all animals were positioned identically. The ECG was
recorded for 15 min with an IWX228 bioamplifier and LabScribe 2 software (iWorx) at a
sampling rate of 2.0 KHz. Rats were then injected via the intraperitoneal route with T. b. bru-
cei Lister 427 or vehicle and then recovered.
Data Acquisition and Analysis for the Lister 427 Infection Model
The ECG data from the last 1 min of the 15 min period collected on both day 0 and day 4 were
averaged using the advanced ECG analysis module (iWorx) and exported to Origin6.1 (Origi-
nLab) for RR interval, heart rate, PR interval and QT interval measurement, with correction for
heart rate using the Framinghammethod [27]. The whole trace was manually assessed for ven-
tricular premature complexes (VPCs) as defined by the Lambeth Conventions [28]; specifically
complexes that were premature, without a well-defined P wave and had a wide and bizarre shape.
Parasitaemia Measurements
Parasitaemia levels were measured daily by microscopy of blood from superficial venepuncture
of the lateral tail vein, as previously described [26]. A parasitaemia level exceeding 5.0 x 108
parasites.mL-1 for more than two consecutive days was set as a cut-off point for the welfare of
the animals. No animal exceeded this level during the study. Day 4 of the Lister 427 model was
selected as the end point based on prior experience with this trypanosome strain in the rat
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infection model in terms of the level of parasitaemia and its impact on the health of the animals
and in order to avoid sudden deaths.
Telemetry Probe Implantation for the TREU 927 Infection Model
For the longer TREU 927 infection model, CA-F40 biopotential recording devices (Data Sci-
ences International) were implanted into rats to measure the ECG in conscious animals. This
allowed the recording and analysis of ECG data without the potential cardiovascular depressive
effects of isoflurane [29;30]. Briefly, adult male Wistar rats (250–300 g) were anaesthetised
with isoflurane delivered in 100% O2. Animals were positioned in ventral recumbency on a
heated pad. Peri-operative analgesia of 5.0 mg.kg-1 carprofen (Rimadyl, Pfizer Animal Health)
was administered in 5.0 mL of 0.9% sterile saline subcutaneously. The telemetry device was im-
planted subcutaneously in the dorsal thoracic region. Tracts were tunnelled under the skin
from the implant site to the right pectoral and xyphoid regions ventrally. The insulation was re-
moved from the distal 5.0 mm of each ECG lead, which were then affixed to the layer of muscle
at each point under the skin with 1.5 metric nylon suture (Johnson & Johnson). Exposed ends
of the leads were re-covered with the removed insulating material. The surgical incisions were
closed with 1.5 metric polyglactan 910 (Vicryl, Johnson & Johnson).
Trypanosome Infections for TREU 927 Infection Model
The animals were allowed to recover from the surgical procedure for 1 week before they were
infected with 1.0 x 105 T. b. brucei TREU 927 in 200 μL CBSS via intraperitoneal injection.
Control rats were injected with the same volume of CBSS. Parasitaemia levels by superficial tail
venepuncture were assessed as previously described.
Data Acquisition and Analysis for TREU 927 Infection Model
The implanted probes were activated magnetically and data was collected from receiver pads
underneath the animals’ usual cages. Telemetry signals were relayed via a data exchange matrix
to a computer loaded with the acquisition software Dataquest™OpenART v4.2 (Data Sciences
International). Raw ECG data was collected at a 2.0 kHz sampling frequency. Files were ex-
ported to Ponemah v4.8 (Data Sciences International) for analysis. ECG sections of 30 min
were averaged and assessed for RR interval, heart rate, PR intervals, and QT intervals corrected
for heart rate using the Framingham method (QTc = QT + 0.154 x (1-RR)). A one hour section
of trace from day 3, 6, 9 and the end of the final day of the protocol—to enable analysis of time
points corresponding with peak and trough parasitaemias—was assessed for arrhythmias using
the Lambeth Conventions as described above and compared to a one hour section of trace after
recovery but prior to infection (day 0).
Organ Harvest
Both control and infected animals for each model were sacrificed by cervical dislocation
while under a brief exposure of low dose 1% isofluorane. Heart, liver and spleen were re-
moved, organ mass recorded and compared to the tibial length defined as the length from lat-
eral femoral epicondyle proximally to the lateral malleolus distally to control for individual
size and mass.
Langendorff Perfusion of Ex Vivo Hearts
The hearts removed from both groups (Lister 427 infection model and TREU 927 infection
model, plus controls) were immersed in ice-cold Tyrodes solution (mM); 116 NaCl, 20
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NaHCO3, 0.4 Na2HPO4, 1.0 MgSO4-7H2O, 4.0 KCl and 11.0 D-glucose. The solution was
bubbled with 95% O2 / 5% CO2 for 15–20 min to oxygenate and buffer before CaCl2 was
added to a concentration of 1.8 mM. Extraneous tissue was carefully dissected away to reveal
the aorta. The hearts were blotted dry and quickly weighed before cannulation to a Langen-
dorff perfusion apparatus. The hearts were perfused with the above Tyrodes solution at 10
mL.min-1 and immersed in a water-jacketed chamber filled with Tyrodes solution at 37°C.
Electrodes were placed in the chamber in close approximation with the right atrium for the
negative electrode and the apex of the left ventricle for the positive electrode and the pseudo-
ECG recorded. Hearts were perfused for a period of 15 min (steady state) followed by 15 min
periods each with the β-adrenergic agonist isoproterenol at concentrations of 100 nM, 1 μM,
10 μM and 100 μM.
Langendorff Data Analysis
ECG data were collected using the ETH-256 bioamplifier (iWorx) and LabChart 7 (ADInstru-
ments) software at a sampling rate of 2.0 kHz. The ECG from the last 5 min of each 15 min pe-
riod was averaged using the advanced ECG analysis module of the programme and the RR
interval, heart rate, PR interval and the QT interval with correction for heart rate using the Fra-
mingham method [27] were measured. Traces were exported to Origin6.1 (OriginLab). The en-
tirety of the traces was manually assessed for arrhythmic events according to the Lambeth
Conventions [28] and recorded as the frequency.min-1.
Histology of Hearts
After Langendorff perfusion, whole hearts were fixed in 10% neutral buffered formalin and sec-
tioned to include a transverse section of the apex and one longitudinal section of the base (to
include the atria) and the apex (3 sections from each heart). These were then routinely pro-
cessed to paraffin wax and serial sections (5 μm) were stained with haematoxylin and eosin
(H&E) for histopathological evaluation of inflammation and Picrosirius red for fibrosis. Select-
ed sections were stained with Giemsa to highlight parasitic organisms. The sections were then
semi-quantitatively scored and assigned a score of 0–3 for degree of inflammation and fibrosis.
The scores of 0–3 were based on the findings of no pathology, mild, moderate and severe
changes respectively. In addition, the presence (1) or absence (0) of parasites and their location
(e.g. interstitial) was noted.
Statistics
For the in vivo Lister 427 infection model, the mean ± SEM data from the last 1 min of ECG
trace for the same animal from day 0 and day 4 were compared with a paired Student’s T-test.
Comparisons of in vivo ECGs between control and infected animals were conducted with a
two-sample Student’s T-test. For the in vivo TREU 927 infection model, mean ± SEM ECG te-
lemetry data were taken from the last 30 min of ECG trace from day 0 and day 11 and com-
pared within each animal by paired Student’s T-test. Comparisons between control and
infected animals were performed by two-sample Student’s T-test. Arrhythmia data for the
TREU 927 infection model were taken from 1 hr long traces at days 0, 3, 6, 9 and the end and
compared to day 0 by ANOVA. Mean ± SEM ECG data was acquired from the average of the
last 5 min of each 15 min section of trace for each concentration of ISO for the ex vivo Langen-
dorff perfused hearts of both the Lister 427 and TREU 927 infection models and analysed
using ANOVA. P<0.05 was taken to be statistically significant.
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Results
In Vivo ECG Parameters for T. b. brucei Lister 427 Infections
The average ECG traces from 15 min periods from days 0 and 4 from anaesthetised rats in
both infection and control groups were analysed for heart rate (HR), PR interval and QT inter-
val (Fig 1A). The Lister 427 infection model was of short duration—animals had to be eutha-
nased on welfare grounds at 4 days post-inoculation. The relatively brief infection period was
due to parasitaemia of the infected rats demonstrating exponential growth (rising to 2.51 x 108
± 1.02 x 108 parasites.mL-1 on day 4; Fig 1B), as was anticipated with this monomorphic try-
panosome strain. There was no significant difference in the HR in the control animals between
days 0 and 4 (99.8 ± 8.6% of day 0; 249 ± 21 vs. 248 ± 21 bpm; Day 0 vs. Day 4; P>0.05), nor
was there a significant difference in the infected animals (94.8 ± 7.9% of day 0; 238 ± 19 vs.
226 ± 19; Day 0 vs. Day 4; P>0.05; Fig 1C(i)). There was no significant difference in PR interval
for the control rats (46.6 ± 0.8 vs. 46.4 ± 1.2 ms; Day 0 vs. Day 4; P>0.05; Fig 1C(ii)), nor for
the infected rats (46.4 ± 0.6 vs. 45.8 ± 0.8 ms; Day 0 vs. Day 4; P>0.05; Fig 1C(ii)). There was
also no significant difference in QTc for control (176.6 ± 3.0 vs. 179.1 ± 2.8 ms; Day 0 vs. Day
4; P>0.05; Fig 1C(iii)) or infected animals (181.3 ± 3.9 vs. 176.2 ± 3.9 ms; Day 0 vs. Day 4;
P>0.05; Fig 1C(iii)). During the 15 min periods of ECG for both the start and end of the study
protocol no ventricular arrhythmic events were observed.
Ex Vivo Langendorff Perfused Heart Pseudo-ECG Parameters for T. b.
brucei Lister 427 Infections
An ECG was performed on perfused hearts isolated from infected animals to determine: (1)
whether cardiac electrical activity was altered in the absence of a systemic autonomic nervous
response or circulating factors and (2) the effect of β-adrenergic stimulation on ECG parame-
ters using isoproterenol (ISO) at increasing doses (100 nM, 1 μM, 10 μM and 100 μM) every 15
min to simulate a stress response (Table 1 and Fig 2A).
When hearts were isolated and perfused ex vivo, no ECG parameters (HR, PR, QTc inter-
vals) were significantly different between control and infected animals (Timepoint 0; Table 1
and Fig 2). HR of control animal hearts (normalised to no ISO) demonstrated a non-significant
increase to 117% of no ISO level (100 ± 8.0 vs. 117 ± 5.0%; no ISO vs. 100 μM ISO; P>0.05; Fig
2B(i and ii) and Table 1). However, hearts from infected animals demonstrated a significant in-
crease in HR to 135% of HR with no ISO (100 ± 8.0 vs. 135 ± 2.0%; no ISO vs. 100 μM ISO;
P<0.05; Fig 2B(i and ii) and Table 1). PR or QTc interval (raw data and data normalised to no
ISO) showed no significant difference between control or infected animals (Table 1 and Fig 2C
and 2D respectively).
Parasitaemia Levels in T. b. brucei TREU 927 Infections
A limitation of the use of T. b. brucei Lister 427 in vivo is that the parasite continues to divide
exponentially within the host’s bloodstream until the death of the host, typically after approxi-
mately 4 days in the rat model. Lister 427 is a monomorphic strain of T. b. brucei, meaning it
remains as the mitotically dividing long slender form [31]. While this continual growth makes
Lister 427 a useful in vitromodel organism, it does not mimic the fluctuating parasitaemia and
more chronic infections [32] observed in human patients and animals infected with trypano-
somes, which is due to the pleomorphism of non-laboratory adapted trypanosomes. Wild-type
pleomorphic trypanosomes such as TREU 927 terminally differentiate to short stumpy forms
under a density-dependent trigger [33] in preparation for transmission to the insect vector
[34;35]. The animals were monitored for health and their parasitaemia was measured daily for
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the duration of the study (Fig 3A). The parasitaemia in the T. b. brucei TREU 927 infected ani-
mals followed the classical fluctuating pattern with a first peak parasitaemia of 3.16 x 107 ±
2.51 x 105 parasites.mL-1 of blood on day 6, before becoming undetectable by microscopy, fol-
lowed by a second peak of 3.56 x 107 ± 1.62 x 107 parasites.mL-1 blood on day 10 (Fig 3B).
Fig 1. In vivo ECG parameters for T. b. brucei Lister 427 infection. A) Protocol used for in vivo T. b. brucei Lister 427 infection model. ECGs were
recorded prior to injection with trypanosomes or control vehicle (CBSS). ECGs were recorded again on day 4 prior to sacrifice. B) Parasitaemia levels for T. b.
brucei Lister 427 infection model. Numbers expressed as parasites.mL-1 of blood x 108. C) (i) Mean percentage change in heart rate on day 4 over heart rate
on day 0. C) (ii-iii) Mean data for PR interval and QT interval corrected for heart via Framinghammethod.
doi:10.1371/journal.pntd.0003811.g001
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In Vivo ECG Parameters for T. b. brucei TREU 927 Infections
The ECG was recorded in both control rats and rats infected with T. b. brucei TREU 927 via
biopotential recording telemeters. Average ECG traces were analysed from day 0 and day 11
(Fig 3A). HR tended to decrease, but not significantly, in the control animals (404 ± 18 vs.
348 ± 12 bpm; Day 0 vs. Day 11; P>0.05). However, there was a significant increase in heart
rate for TREU 927 infected animals of 117.8 ± 5.0% of day 0 (351 ± 22 vs. 413 ± 18 bpm; Day 0
vs. Day 11; P<0.05; Fig 3C(i)). There was no significant difference in PR interval for control
(43.2 ± 1.7 vs. 42.6 ± 1.5 ms; Day 0 vs. Day 11; P>0.05; Fig 3C(ii)) or infected animals
(41.5 ± 1.7 vs. 44.1 ± 3.2 ms; Day 0 vs. Day 11; P>0.05; Fig 3C(ii)). When the QT interval was
corrected for HR using the Framingham method there was no significant difference for control
animals (181.9 ± 4.4 vs. 190.1 ± 11.8 ms; Day 0 vs. Day 14; P>0.05; Fig 3C(iii)) or infected ani-
mals (185.2 ± 7.2 vs. 192.6 ± 6.9 bpm; Day 0 vs. Day 14; P>0.05; Fig 3C(iii)). The frequency of
arrhythmic events including VPCs, did not significantly change in control animals
(0.027 ± 0.019 vs. 0.047 ± 0.017 VPC.min-1; Day 0 vs. Day 11; P>0.05; Fig 3D(i)). However,
during progression of infection with T. b. brucei TREU 927, when the arrhythmia frequency
was examined at 3 day intervals to take into account both peaks and troughs of parasitaemia,
the frequency increased over the course of the model to a final significant increase of 442% of
Day 0 levels at Day 11 (0.113 ± 0.039 vs. 0.500 ± 0.234 VPC.min-1; Day 0 vs. Day 11; P<0.05;
Fig 3D(i and ii)). Arrhythmia frequency did not parallel parasitaemia level since the arrhythmia
frequency did not concomitantly reduce with the parasitaemia when examined at Day 9
(0.307 ± 0.199 VPC.min-1; Day 9; Fig 3D(i)).
Ex Vivo Langendorff Perfused Heart Pseudo-ECG Parameters for T. b.
brucei TREU 927 Infections
As with the Lister 427 infection model, hearts were isolated from the TREU 927 infection
model animals and an ECG performed in the presence and absence of ISO (Table 2 and Fig
4A). When hearts were isolated and perfused ex vivo, no ECG parameters (HR, PR, QTc inter-
vals) were significantly different between control and infected animals (Timepoint 0; Table 2).
The control animal HR (normalised to no ISO), demonstrated a significant increase to 117% of
no ISO level (100 ± 6.0 vs. 117 ± 7.0%; no ISO vs. 100 μM ISO; P>0.05; Fig 4B(i and ii) and
Table 2) compared to an increase to 149% of no ISO level for infected hearts (100 ± 5.0 vs.
149 ± 8.0; no ISO vs. 100 μM ISO; P<0.05; Fig 4B(i and ii) and Table 2). The PR interval (nor-
malised to no ISO), demonstrated a significant difference between control and infected hearts
but only at 1 μM ISO (100 ± 9.0 vs. 80.2 ± 4.9%; no ISO vs. 1μM ISO; P<0.05; Fig 4C(i & ii)
and Table 2). No significant changes in the QTc (when normalised to no ISO) were observed
(Fig 4D(i & ii) and Table 2).
Table 1. T. b. brucei Lister 427 ex vivo Langendorff parameters.
ISO (μM) Heart Rate (bpm)* PR Interval (ms)* QTc (Framingham (ms))
Control (n = 4) Infected(n = 4) P value Control (n = 4) Infected(n = 4) P value Control (n = 4) Infected (n = 4) P value
0 308 ± 26 269 ± 22 0.295 42.3±4.3 39.6±2.5 0.605 195.3±6.8 197.8±3.3 0.750
0.1 353 ± 25 331 ± 11 0.431 36.1±2.2 34.9±1.7 0.673 195.7±6.0 198.9±3.7 0.665
1.0 337 ± 10 349 ± 11 0.472 32.2±1.8 36.4±2.6 0.239 197.4±7.0 203.0±3.6 0.502
10.0 359 ± 10 360 ± 1 0.963 35.9±2.8 37.9±7.9 0.767 199.4±6.2 209.3±0.8 0.343
100.0 360 ± 14 363 ± 4 0.880 36.5±2.8 37.9±7.3 0.826 201.0±5.8 204.9±2.6 0.685
*bpm; beats per minute, ms; milliseconds
doi:10.1371/journal.pntd.0003811.t001
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Fig 2. Ex vivo Langendorff ECG parameters for T. b. brucei Lister 427 infection. A) Protocol used in Langendorff perfusion experiments. Increasing
concentrations of isoproterenol were added every 15 min and the ECG recorded throughout. B) (i) Mean ± SEM heart rate data (values also in Table 1) and
(ii) heart rate normalised to no ISO. C) (i) Mean ± SEM PR interval data (values also in Table 1) and (ii) PR interval normalised to no ISO. D) (i) Mean ± SEM
QT interval corrected for heart rate (QTc) (values also in Table 1) and (ii) QT interval corrected for heart rate normalised to no ISO. Statistics performed on
raw data by paired Student’s T-test to no ISO, P<0.05 taken as significant denoted by *.
doi:10.1371/journal.pntd.0003811.g002
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Fig 3. In vivo ECG parameters for T. b. brucei TREU 927 infection. A) Protocol used for in vivo T. b. brucei TREU 927 infection model. B) Parasitaemia
levels for T. b. brucei TREU 927 infection model. Numbers expressed as parasites.ml-1 of blood x 107 (n = 5). C) (i) Mean percentage change in heart rate on
day 11 over heart rate on day 0. C) (ii-iii) Mean data for PR interval and QT interval corrected for heart via Framinghammethod from average traces taken
prior to injection and end of the protocol. D) (i) Mean data for frequency of VPCs per min at days 3, 6, 9 and at the end of the model. D) (ii) Example trace from
a TREU 927 infected animal.
doi:10.1371/journal.pntd.0003811.g003
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T. b. brucei TREU 927 Infected Ex Vivo Hearts Show Increased
Frequency of Arrhythmias in the Presence of Isoproterenol
The pseudo-ECGs from the Langendorff perfused hearts from both models were also assessed
for the frequency of VPCs with and without the presence of ISO (Fig 5A). There was no signifi-
cant increase in VPC frequency in control hearts or the Lister 427 infection model hearts (Fig
5B and 5D(i)) both in the absence and presence of ISO. However, the TREU 927 infection
model hearts demonstrated an increase in VPC frequency in the presence of ISO compared
with control hearts (significant at 1 μM) (0.24 ± 0.16 vs. 5.24 ± 4.99 vs. 5.48 ± 1.83 (P<0.05) vs.
10.4 ± 8.9 VPC.min-1; no ISO vs. 100 nM vs. 1 μM vs. 10 μM ISO; Fig 5C and 5D(ii)) but not in
the absence of ISO.
Histology of T. b. brucei Infected Hearts
Histopathological evaluation of the hearts from both control (Fig 6A(i)) and infection models
(Fig 6A(ii)) subsequent to Langendorff perfusion revealed the presence of parasites within the
interstitium (parasite extravasation) in close proximity to cardiomyocytes in 3 out of 3 (100%)
of the TREU 927 infection model hearts but in 0 out of 4 hearts (0%) from the Lister 427 infec-
tion model and 11 control hearts (Fig 6A(iii) and 6B(i)). The level of inflammation was higher
in hearts from the TREU 927 infection model compared to control and Lister 427 infected
hearts (Fig 6A(iv) and 6B(ii)). There was no significant change in the degree of fibrosis between
any group of hearts (Fig 6(iii)).
OrganWeights in the Lister 427 and TREU 927 Infection Models
When animals were sacrificed, the mass/tibial length ratio of the heart, liver and spleen were re-
corded. Heart and liver mass/tibial length ratios were not significantly different between in-
fected animals and controls for either the Lister 427 infection model or the TREU 927 infection
model (see S1A(i–v) Fig and S2(i–iii) Fig However, the spleen mass/tibial length ratios were
significantly increased in both the Lister 427 infection model by 199% (13.3 ± 0.4 vs. 26.5 ± 3.4
mg.mm-1; control vs. infected; P<0.05; S1(v) and S1B Fig) and the TREU 927 infection model
by 292% (17.2 ± 1.6 vs. 50.2 ± 7.5 mg.mm-1; P<0.05; S2A(iv) Fig).
Discussion
In Vivo ECG Parameters for T. b. brucei Lister 427 Infections
We have previously demonstrated that even in the absence of a host systemic inflammatory/im-
mune response to the parasite, ventricular arrhythmias can be induced by Lister 427 trypano-
somes ex vivo due to the effect of a secreted/excreted protease, T. brucei cathepsin-L (TbCatL), on
Table 2. T. b. brucei TREU 927 ex vivo Langendorff parameters.
ISO (μM) Heart Rate (bpm)* PR Interval (ms)* QTc (Framingham (ms))
Control (n = 5) Infected(n = 5) P value Control (n = 5) Infected(n = 5) P value Control (n = 5) Infected (n = 5) P value
0 280 ± 16 239 ± 11 0.073 37.4±3.2 39.1±1.7 0.665 203.3±4.9 187.8±12.0 0.265
0.1 317 ± 4 350 ± 31 0.321 31.1±2.2 37.1±4.3 0.245 206.3±3.2 194.2±2.2 0.015
1.0 336 ± 18 345 ± 23 0.780 30.0±2.0 37.5±1.9 0.028 206.5±2.8 202.8±2.8 0.451
10.0 319 ± 5 350 ± 14 0.073 31.1±2.3 38.3±3.5 0.118 209.1±4.3 206.8±2.4 0.655
100.0 328 ± 20 356 ± 19 0.334 33.2±3.4 39.5±3.9 0.252 209.5±4.4 211.9±2.8 0.657
*bpm; beats per minute, ms; milliseconds
doi:10.1371/journal.pntd.0003811.t002
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Fig 4. Ex vivo Langendorff ECG parameters for T. b. brucei TREU 927 infection. A) Protocol used in Langendorff perfusion experiments. Increasing
concentrations of isoproterenol were added every 15 min and the ECG recorded throughout. B) (i) Mean ± SEM heart rate data (values also in Table 2) and
(ii) Heart rate normalised to no ISO. C) (i) Mean ± SEM PR interval data (values also in Table 2) and (ii) PR interval normalised to no ISO. D) (i) Mean ± SEM
QT interval corrected for heart rate (QTc) (values in also Table 2) and (ii) QT interval corrected for heart rate normalised to no ISO. Statistics performed on
raw data by paired Student’s T-test to no ISO, P<0.05 taken as significant denoted by *.
doi:10.1371/journal.pntd.0003811.g004
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Fig 5. Arrhythmic events in Langendorff perfused infected and control hearts. A) Protocol used for Langendorff perfusion experiments. Hearts were
perfused at a rate of 10 mL.min-1 for 15 min steady state followed by 15 min with increasing concentrations of isoproterenol (100 nM, 1 μM, and 10 μM). B-C)
(i-ii) Example pseudo-ECGs from Langendorff perfused heart from TREU 927 infected animal and corresponding control. D) Mean ± SEM for frequency of
ventricular premature complexes (VPCs) for (i) T. b. brucei Lister 427 and (ii) T. b. brucei TREU 927.
doi:10.1371/journal.pntd.0003811.g005
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cardiomyocytes [24]. However, no significant ECG abnormalities were apparent between the con-
trol and infected animals in vivo. Four explanations may account for this. First is the use of anaes-
thesia in the Lister 427 model compared with conscious ECGmonitoring in the TREU 927 model.
It is possible that the anaesthesia (isofluorane) used in the Lister 427 model reduced the propensity
for arrhythmias, but to the best of our knowledge there is little evidence that isofluorane can re-
duce the incidence of arrhythmias. Secondly, the brevity of the infection period may limit appre-
ciable extravasation of the parasite into the cardiac extracellular matrix. This possibility is
Fig 6. Histology of infected hearts. A) Atrio-ventricular region from (i) control and (ii) TREU 927 infected
hearts (H&E). Higher magnification demonstrating (iii) parasite extravasation (Giemsa) and (iv) inflammation
(H&E). B) Mean ± SEM of semi-quantitative pathological scoring (0–3; see methods) for: (i) parasite
extravasation, (ii) inflammation and (iii) fibrosis.
doi:10.1371/journal.pntd.0003811.g006
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supported by histological examination of Lister 427 infected hearts, in which no parasites could be
identified in the interstitium, suggesting that extravasation had not occurred with this strain—at
least within the limits of detection. Connected to the brevity of the infection period, exposure time
of cardiomyocytes to parasites and parasite products in the Lister 427 model is clearly much less
than that of the TREU 927 model. However, it is important to note that the parasite burden within
Lister 427 infected animals is much greater than the TREU 927 model (2.51 x 108 ± 1.02 x 108 par-
asites.mL-1 compared to 3.56 x 107 ± 1.62 x 107 parasites.mL-1, respectively, at peak parasitaemia).
On balance therefore it is difficult to conclude that the brevity of infection period leading to re-
duced exposure time of cardiomyocytes to parasites and parasite products exclusively explains an
absence of arrhythmias in the 427 infection model. Thirdly, Lister 427 does not readily extravasate
without existing tissue damage from an inflammatory processes [36]. In the current study, histo-
logical examination confirmed that the level of inflammation in Lister 427 hearts was not signifi-
cantly different from that in control hearts. Finally, it is probable that the amount of TbCatL
produced by Lister 427 is significantly lower than that produced by pleomorphic trypanosomes
such as TREU 927. Caffrey et al. (2001) demonstrated that short-stumpy form trypanosomes pro-
duce almost five times the amount of TbCatL compared to long-slender forms [37]. Since the List-
er 427 strain does not differentiate and remains as a long-slender form, the quantity of TbCatL
produced is very likely to be lower and contribute to the lack of response observed.
HR Changes in Ex Vivo Hearts from T. b. brucei Lister 427 Infected
Animals
During pathophysiological stress, there are increased levels of circulating catecholamines
(adrenaline and noradrenaline). In a previous study, ex vivo hearts demonstrated a significantly
higher frequency of ventricular arrhythmias (ventricular premature complexes, VPCs) in re-
sponse to trypanosome culture supernatant and isoproterenol (ISO; a β-adrenergic agonist)
[24]. This effect was mediated by a CaMKII-dependent increase of spontaneous sarcoplasmic
reticulum (SR)-mediated Ca2+ release events (Ca2+ waves) [24;38]. In the current study, ex vivo
hearts from the Lister 427 infection model demonstrated no increase in arrhythmic events but
a significantly increased HR in response to ISO. HR is dictated by the rate that sinoatrial nodal
pacemaker cells (SANC) in the heart fire spontaneous action potentials. It is possible that the
Lister 427 infection model induces a higher HR due to: 1) a greater sensitivity of the sinoatrial
nodal pacemaker cells (SANC) to β-adrenergic stimulation as can happen in heart failure [39];
2) altered expression/heterodimerisation/polymorphisms of β1 adrenergic receptors [40;41] in
SANC; 3) altered expression of ion channels governing SANC pace making such as hyperpolar-
isation and cyclic nucleotide (HCN) channels [42], G-protein-activated inwardly rectifying po-
tassium (GIRK) channels [43] or calcium channels [44]; 4) altered rate of SANC action
potential firing due to changes in Ca2+ handling protein activity [44;45]. CaMKII-mediated
phosphorylation of Ca2+ handling proteins may alter HR via modulation of the rate of action
potential firing from SANCs [45]. The possibility that the observed HR change in the current
study may be a CaMKII-mediated effect on Ca2+ handling in SANCs in response to trypano-
somes warrants future investigation. The implications of a stress-induced increased HR during
trypanosome infection are important as this may in turn lead to an increased metabolic de-
mand on the heart at the expense of the other organs [46;47]. Given that patients with AT can
die from multiple organ failure [32] this increased metabolic demand is potentially significant.
Ex Vivo ECG Parameters for T. b. brucei Lister 427 Infections
The PR interval was not significantly altered by infection with Lister 427, but tended to de-
crease at 1 μM ISO in control animals while remaining unchanged in infected animals. A
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failure for the PR interval to shorten under β-adrenergic stimulation may reflect a decreased
ability of atrio-ventricular (AV) node conduction velocity to respond to β-adrenergic stimula-
tion (1st degree AV block) [48]. A PR interval of>200 ms has been reported in 3.7–14% of
HAT patients and was defined as 1st degree AV block [15;18]. However, a separate study Blum
et al. (2007) did not observe a significant change in PR interval in patients with HAT [19]. It is
therefore unclear whether trypanosome infection consistently results in altered AV node
conduction velocity.
The QTc was not significantly affected by infection with Lister 427. A prolongation of QTc
during clinical infection may be attributed to myocardial inflammatory infiltration leading to
altered electrical conductivity [9;12]. The cause of the QTc prolongation identified by Blum
et al. (2007) was not investigated but ascribed to the historical observation of myocardial in-
flammatory infiltration in patients with HAT [19].
In Vivo ECG Parameters for T. b. brucei TREU 927 Infections
The pleomorphic strain T. b. brucei TREU 927 was used to more closely approximate a natural
infection. This TREU 927 infection model demonstrated the classical undulating parasitaemia
phenotype (Fig 3B) and was sustainable over a longer time period (up to 11 days) compared to
the four-day infection model of Lister 427. Implanted biopotential recording devices had the
additional advantage of avoiding any cardio-depressive effect of anaesthesia while assessing
ECG parameters. In parallel with the Lister 427 infection model, the PR and QTc interval was
not significantly altered in the TREU 927 infection model. However, the normalised HR of the
TREU 927 infected animals in vivo was significantly increased. It is unknown whether the
anaesthetic regime used during ECG assessment in the Lister 427 infection model masked an
increased HR. Interestingly, a significant increase in the frequency of ventricular arrhythmias
(VPCs) with the TREU 927 infection model was also observed in vivo. The change in arrhyth-
mia frequency increased over the course of the model independent of the parasitaemia level
since the arrhythmia frequency remained increased when the parasitaemia reduced after the
first peak. This provides further evidence that African trypanosomes increase the propensity
for ventricular arrhythmias in vivo.
HR Changes in Ex Vivo Hearts from T. b. brucei TREU 927 Infections
As with the Lister 427 infection model, increasing concentrations of ISO elevated HR to a
greater degree in TREU 927 infected hearts. This supports an effect of trypanosome infection
on the response of the SANCs to ISO. Interestingly, HR in vivo was significantly increased in
the TREU 927 infection model (Fig 3C(i)), an effect lost upon removal of the heart ex vivo, but
reintroduced with the addition of ISO. It is possible that a circulating factor (which ISO simu-
lates) underlies the effect on HR observed in the TREU 927 infection model in vivo.
Ex Vivo ECG Parameters for T. b. brucei TREU 927 Infections
In parallel with the Lister 427 infection model, the PR interval tended to decrease in control an-
imals with a significant decrease in control animals at 1 μM ISO compared to no ISO, and was
significantly reduced compared to PR intervals in infected animals at 0.1, 1 and 10 μM ISO. Al-
though this suggests an effect on AV node conduction velocity similar to that reported in a pro-
portion of HAT cases [15;18], the lack of PR interval effect in rats in vivo suggests that
alteration of AV node conduction velocity may not be a significant feature in the rat in vivo
model of trypanosome infection. The QTc was not significantly altered despite an increase in
the level of inflammation (Fig 6B(ii)). It may be possible that the levels of inflammation in the
TREU 927 infection model were insufficient to induce a prolongation of the QTc interval as
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observed in patients with HAT, which is understandable given that HAT is a chronic disease of
months to years. However, it should be noted that direct comparison of QT intervals between
rats and humans should be interpreted with care since different channels are responsible for
QT interval control in these species [49].
T. b. brucei TREU 927 Infected Ex Vivo Hearts Show an Increased
Frequency of Arrhythmias
Increased VPC frequency was observed in the TREU 927 infection model in vivo in parallel
with increased levels of inflammation and the presence of extravasated parasites. However,
VPCs were absent when the same hearts were isolated ex vivo, only re-emerging in the pres-
ence of ISO. These novel data suggest that African trypanosomes create an arrhythmogenic
substrate in the heart, which when triggered by circulating factor(s) increases the propensity
for ventricular arrhythmias. The generation of an arrhythmogenic substrate in the current
study is not caused by a significant increase of fibrosis (a known arrhythmogenic factor) in the
TREU 927 infection model (Fig 6). However, the increased levels of inflammation observed
and the ability of T. b. brucei TREU 927 to extravasate into the myocardium—both of which
occur despite the parasitaemia levels being approximately 7 fold lower than with T. b. brucei
Lister 427—are likely contributors to the arrhythmogenic substrate. Importantly, the ex vivo
data reveal that these two factors by themselves are not able to lead to arrhythmias without an
additional circulating trigger. It is possible that β-adrenergic stimulation such as circulating
adrenaline/noradrenaline in vivo is the trigger for ventricular arrhythmias during trypano-
some infection and is mimicked by ISO when applied to ex vivo hearts from infected animals.
Whether the expected elevated levels of trypanosome-secreted TbCatL (compared with the
Lister 427 infection model) in vivo contribute to the trigger via increased CaMKII activity (as
would occur with β-adrenergic stimulation [50]) remains unknown and warrants further in-
vestigation in future studies.
Study Limitations
There are key differences in the infection profiles of the monomorphic and pleomorphic infec-
tion models that make direct comparison between the models difficult. The exponential nature
of parasite multiplication in the monomorphic Lister 427 model removes the ability to examine
infections beyond the first peak of parasitaemia. This biological limitation also results in a lack
of representation of parasite life cycle stages (i.e. short stumpy trypanosomes) relevant to infec-
tions in the field, resulting in restricted utility of the monomorphic model for exploring cardiac
pathogenesis in a meaningful manner. The novel data therefore highlight the requirement for
infection models that are capable of reflecting the chronic infection profiles of HAT and AAT
infections (e.g. pleomorphic TREU 927) to study HAT-induced cardiac pathophysiology.
Conclusion
The current study has successfully characterised in vivo cardiac electrical dysfunction in two in-
fection models of African trypanosomes. We have demonstrated for the first time that infection
with a pleomorphic strain of African trypanosome produces an increased frequency of ventric-
ular arrhythmias and provide evidence that this phenomenon requires a circulating factor in
combination with trypanosome infection. This novel animal model of African trypanosomiasis
provides a highly attractive platform to further study the cardiac/other organ-related patho-
physiology of African trypanosomiasis and the efficacy of therapeutic strategies to treat this
neglected disease.
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Supporting Information
S1 Fig. Organ mass data for T. b. brucei Lister 427 infection model. (A(i)) Mean ± SEM for
body mass (302.7 ± 4.1 vs. 301.0 ± 3.1 g; control (n = 24) vs. infected (n = 21); P>0.05). (ii-iv)
Mean ± SEM for organ mass to tibial length ratio for heart (29.3 ± 2.7 vs. 27.8 ± 4.8 mg.mm-1;
control vs. infected; P>0.05), liver (226.5 ± 5.7 vs. 246.2 ± 8.7 mg.mm-1; control vs. infected;
P>0.05), lung (33.1 ± 2.6 vs. 31.4 ± 1.9 mg.mm-1; control vs. infected; P>0.05) and spleen
(13.3 ± 0.4 vs. 26.5 ± 3.4 mg.mm-1; control vs. infected; P<0.05). (B) Photograph of
splenic enlargement.
(TIF)
S2 Fig. Organ mass data for T. b. brucei TREU 927 infection model. (A(i)) Mean ± SEM for
body mass (344.0 ± 8.5 vs. 314.7 ± 15.3 g; control (n = 5) vs. infected (n = 5); P>0.05). (ii-iv)
Mean ± SEM for organ mass to tibial length ratio for heart (34.1 ± 3.4 vs. 31.8 ± 5.6 mg.mm-1;
control vs. infected; P>0.05), liver (253.3 ± 8.9 vs. 244.7 ± 17.6 mg.mm-1; control vs. infected;
P>0.05) and spleen (17.2 ± 1.6 vs. 50.2 ± 7.5 mg.mm-1; control vs. infected; P<0.05).
(TIF)
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